The increase in cAMP levels in -cells is a consequence of GLP-1R activation in these cells, which in turn enhances the secretion of growth inhibitory hormone through signaling pathways such as PKA and Calcium/Calmodulin-dependent protein kinase (Brereton et al., 2015)
The reality: Cost : At $900$1,500 per month, these drugs can add up to $50,000+ over 5 years
Third-party researchers combining lower doses with behavior change are seeing similar impact
The conclusion: marketing claims substantially exceeded the available evidence
Importantly, this increased GCG receptor activity did not adversely impact glycemic control
In short, because subcutaneous injections release medication gradually, its the best way to maintain stable Semaglutide levels, which improves treatment effectiveness as well as reducing potential side effects like nausea